Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas

Clicks: 175
ID: 117039
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #59 of 85 articles by views in Annals of hematology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Computed tomography (CT) as a routine follow-up has been a standard practice for patients with non-Hodgkin lymphoma although it is not recommended in most guidelines. We aimed to describe the value of surveillance CT in detection of disease relapse in patients with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma grade 3 (FL3) and to evaluate whether relapse detected by different methods influenced outcome. In this retrospective review of consecutive 341 patients with DLBCL or FL3 diagnosed between 2003 and 2009 in complete response (CR) or unconfirmed CR, 113 patients experienced relapses. We found that routine surveillance CT detected asymptomatic relapse in 25 patients (22.1 %; group 1), including 22 of 100 patients with DLBCL and three of 13 with FL3. The first presentation of relapse of the other 88 patients (group 2) included patient-reported symptoms (60.2 %), physical examination (13.3 %), or abnormal laboratory data (4.4 %). For 72 patients received chemotherapy after relapse, the overall survival after relapse was not different between groups 1 and 2 (p = 0.569). The results of our study suggested that routine surveillance CT only has a limited role in the early detection of relapse and the relapse detected by surveillance CT or not has no impact on survival after relapse for patients with DLBCL or FL3.
Reference Key
lin2012annalsvalue Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tung-Liang Lin;Ming-Chung Kuo;Lee-Yung Shih;Po Dunn;Po-Nan Wang;Jin-Hou Wu;Tzung-Chih Tang;Hung Chang;Yu-Shin Hung;Shu-Chen Lu;Tung-Liang Lin;Ming-Chung Kuo;Lee-Yung Shih;Po Dunn;Po-Nan Wang;Jin-Hou Wu;Tzung-Chih Tang;Hung Chang;Yu-Shin Hung;Shu-Chen Lu;
Journal Annals of hematology
Year 2012
DOI
doi:10.1007/s00277-012-1508-0
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.